Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis enabler. These devices have large commercial potential

The Market Herald Price Sensitive
{{currentVideo.title}} {{currentVideo.relativeTime}}
{{currentVideo.storiesTitle}}:
{{story.companySymbol}}
{{story.companySymbol}} {{story.headline}}
< Previous bulletin
Next bulletin >
Spectral Medical Inc > Don't sell your shares!
View modes: 

Don't sell your shares!

Spectracles (7) | July 20, 2022 01:21 pm

Hold tight and buy more from the bashers if you can. This ride is getting to the good part. Every penny is $7500 to me so even a 10 bagger would be rather pleasant. Go Spectral!

RE:Don't sell your shares!

Gorf79 (371) | July 20, 2022 01:25 pm

You absolutely  stole those 20,000 shares... absolutely stole them!

RE:RE:Don't sell your shares!

Spectracles (7) | July 20, 2022 01:44 pm

I meant that for every penny it goes up I earn $7500. When it comes to how long those on this board have owner Spectral I may well be the winner.

RE:RE:RE:Don't sell your shares!

Gorf79 (371) | July 20, 2022 01:50 pm

2004 for me!

I sold shares once in 18 years but have made 79 individual purchases according to my log notes.

It hasn't even started to move yet and not until $2.00 Will
I change that opinion.

I'm looking for $30.00 USD a per share for half the company!

RE:RE:RE:Don't sell your shares!

gebremeskel (225) | July 20, 2022 02:21 pm

I'm a relative newcomer. But I've been here long enough to have been sadly holding an almost empty bag on Oct. 3, 2016 when the previous trial failed. Now that things are looking up I'm glad I held on to my original shares. I just bought more at 46 cents. 

Spectracles wrote: I meant that for every penny it goes up I earn $7500. When it comes to how long those on this board have owner Spectral I may well be the winner.


RE:RE:RE:RE:Don't sell your shares!

TechOne (137) | July 20, 2022 08:51 pm

Long term share holders all know the prospects in terms of PMX, history, in terms of previous results as well as new TIGRIS trial with enough leeway to allow them to do a proper job of it, all the numbers from Japan and Italy and previous study there and now with selected patients being enrolled at a steady clip, it is as good as it is going to get..  Today's news release was totally unexpected since the management had made it clear that they were not going to jeopardize the trial and run afoul with FDA by issuing any premature results..

And let's not forget that Spectral is not a one trick poney.. Dialco with already approved SAMI and pretty soon the DIMI we have a subsidiary that is worth any where from half a billion to as much as 2 billion if previous deals are any guide.. We already have one deal and with the new guy, whose claim to fame is his rolodex with access to all manners of right people, we are going to be surprised one of these days with some other deals.. Hopefully..

So who in their right mind would sell the shares where the marketcap is a lousy 150+ million..

No doubt, The game is afoot.. Every news release that comes out of the company will be looked over closely and parsed for sure.. Breakthrough Device designation and if we have interim results at some point that blows out the numbers, anything is possible..

FWIW

p.s. And yes, a .01 move in shares is worth a lot of money, up or down, for some of the players here so let's not even go there.. :)

RE:RE:RE:RE:RE:Don't sell your shares!

Gorf79 (371) | July 20, 2022 11:01 pm

Well Said Tech one.

And you are spot on in your take, particularly with Dialco, although I think your valuation is light by two thirds.

PMX and Baxter seem to be dominating the posts this week. It is easy to lose track of the recently COMMERCIAL Dialco division, and their own two pronged approach to the ownership of the in in-clinic/hospital and home dialysis market for years to come.


DIALCO the WHOLLY OWNED DIALYSIS DIVISION: FDA Approved, Cloud connected, touch screen controlled, cost effective, excellent safety profile, easy to use, instantaneous monitoring by client's physician, innovative, clean sheet design, intuitive, 10 year competitive regulatory lead, portable and set to absolutely hammer the competition!!!.... And it did with the very recent ARC Dialysis deal!

That is an oversight that is easy to make if you are a new or prospective investor.

If we had an attentive, non hibernating analyst Stockhouse would not be the only source of opinion on Spectral but such is the case.

Thanks again!

RE:RE:RE:RE:RE:Don't sell your shares!

GeneralAladeen (87) | July 21, 2022 09:46 pm

Techone. Nice to hear from you on Spectal board, not only on the NPK - Verde Agritech board (where you input is great) You're one of the few posters on here that I know don't have an agenda. 

Great post! I only have 30,000 shares of EDT, but always interested in releases like yesterdays. Certainly is somewhat anecdotal but nice to see nonetheless. This .54 SP is confusing with all Spectral has going but I will hold to the bitter end to see what comes of this gem? Can't say the company has managed funds particularly well, but they seem to have the holy grail for Sepsis.

We should have the normal run up to FDA decision time (whenever that is) next summer fall? But the real catalyst seems to be either a Baxter Buyout, FDA approval or revenue exploding. Any of those would be nice.

I had a family member die of Sepsis several years ago, so I am always wishing for FDA to approve this game changing device to help other families.   Let hope it's a home run and not another Canadian Biotech dud. My money says winner....we shall see:-) good luck with all your investments!! 

RE:RE:RE:RE:RE:RE:Don't sell your shares!

TechOne (137) | July 22, 2022 04:02 am

Thanks GAla.. 

Would not it be something if Spectral share price manage to do what Verde has done.?? We can use a 10-20 bagger.. 

However, we know Small BioTechs are notoriously hard to go the distance but for now Spectral has a lot going for it.. Dialco alone is worth a lot more then current marketcap of Spectral so I am hopeful eventually markets will give them their due..

I agree that management has diluted the capital base quite a bit but on the other hand, some of it has been beyond their control..  Launching Dialco with SAMI and DIMI was a life saver in turning the company's prospects should the PMX trial disappoint.. Hopefully not.. 

My cousing died 4 years ago due to Sepsis as well.. Rather young too, at 50+  I am sure every family has a story so even if limited in application, hopefully it will be save a lot of patients so beside looking for a winner as an investment, there are more valid reasons for cheering the company to deliver..

FWIW